<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="fbln5-cutis-laxa" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">fbln5-cutis-laxa</book-part-id>
      <title-group>
        <title>
<italic toggle="yes">FBLN5</italic>-Related Cutis Laxa</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Van Maldergem</surname>
            <given-names>Lionel</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <aff>Centre de g&#x000e9;n&#x000e9;tique humaine<break/>CHU<break/>Universit&#x000e9; de Franche-Comt&#x000e9;<break/>Besan&#x000e7;on, France</aff>
          <email>vmald@skypro.be</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Loeys</surname>
            <given-names>Bart</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <aff>Center for Medical Genetics<break/>Antwerp University Hospital<break/>Edegem, Belgium</aff>
          <email>bart.loeys@ua.ac.be</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date iso-8601-date="2009-03-19" date-type="created">
          <day>19</day>
          <month>3</month>
          <year>2009</year>
        </date>
        <date iso-8601-date="2014-03-13" date-type="updated">
          <day>13</day>
          <month>3</month>
          <year>2014</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="ee" document-type="chapter">Ethylmalonic Encephalopathy</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="fbxl4-mtddepl" document-type="chapter"><italic toggle="yes">FBXL4</italic>-Related Encephalomyopathic Mitochondrial DNA Depletion Syndrome</related-object>
      <abstract id="fbln5-cutis-laxa.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p><italic toggle="yes">FBLN5</italic>-related cutis laxa is characterized by cutis laxa, early childhood-onset pulmonary emphysema, peripheral pulmonary artery stenosis, and other evidence of a generalized connective disorder such as inguinal hernias and hollow viscus diverticula (e.g., intestine, bladder). Occasionally, supravalvular aortic stenosis is observed. Intrafamilial variability in age of onset is observed. Cardiorespiratory failure from complications of pulmonary emphysema (respiratory or cardiac insufficiency) is the most common cause of death.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>Diagnosis is based on clinical findings and electron microscopic (EM) findings on skin biopsy. <italic toggle="yes">FBLN5</italic> is the only gene in which pathogenic variants cause this disorder.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Routine repair of inguinal hernias; repeat plastic surgery of the face and trunk as needed; symptomatic treatment of pulmonary emphysema. No treatment is available for the arterial abnormalities.</p>
          <p><italic toggle="yes">Prevention of secondary complications:</italic> Attention to respiratory function prior to surgery; prophylactic antibiotics as needed for vesicoureteral reflux.</p>
          <p><italic toggle="yes">Agents/circumstances to avoid:</italic> Smoking.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p><italic toggle="yes">FBLN5</italic>-related cutis laxa can be inherited in an autosomal recessive or autosomal dominant manner. Autosomal recessive inheritance is more common.</p>
          <list list-type="bullet">
            <list-item>
              <p><italic toggle="yes">Autosomal recessive inheritance:</italic> At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier.</p>
            </list-item>
            <list-item>
              <p><italic toggle="yes">Autosomal dominant inheritance:</italic> Each child of an individual with autosomal dominant cutis laxa has a 50% chance of inheriting the pathogenic variant.</p>
            </list-item>
          </list>
          <p>Prenatal testing is possible for pregnancies at increased risk in families in which the pathogenic variant(s) have been identified.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="fbln5-cutis-laxa.Diagnosis">
        <title>Diagnosis</title>
        <sec id="fbln5-cutis-laxa.Clinical_Diagnosis">
          <title>Clinical Diagnosis</title>
          <p><italic toggle="yes">FBLN5</italic>-related cutis laxa is diagnosed in individuals with the following:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Cutis laxa.</bold> Furrowing of the skin of the whole body that is particularly obvious in neck, axillae, and groin. The face has a &#x0201c;droopy&#x0201d; appearance with eyelid ptosis and drooping cheeks. When one tries to extend the skin, it does not display hyperelasticity as in the Ehlers-Danlos syndromes, but rather keeps its consistency.</p>
            </list-item>
            <list-item>
              <p><bold>Pulmonary emphysema.</bold> Pulmonary emphysema is usually seen at an early age, including the neonatal period.</p>
            </list-item>
            <list-item>
              <p><bold>Arterial involvement.</bold> Peripheral pulmonary artery stenosis appears to be specific for this disorder. Some affected individuals also display supravalvular aortic stenosis.</p>
            </list-item>
            <list-item>
              <p>
                <bold>Other evidence of a generalized connective disorder</bold>
              </p>
              <list list-type="bullet">
                <list-item>
                  <p>Inguinal hernias</p>
                </list-item>
                <list-item>
                  <p>Hollow viscus diverticula (e.g., intestine, bladder)</p>
                </list-item>
                <list-item>
                  <p>Pyloric stenosis</p>
                </list-item>
              </list>
            </list-item>
          </list>
        </sec>
        <sec id="fbln5-cutis-laxa.Testing">
          <title>Testing</title>
          <p><bold>Skin biopsy</bold>
<bold>with orcein staining on paraffin-embedded samples</bold></p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Light microscopy.</bold> Normal or mild fragmentation and paucity/absence of elastic fibers</p>
            </list-item>
            <list-item>
              <p><bold>Electron microscopy (EM).</bold> Paucity of elastic fibers with accumulation of elastin (ELN) globules, reflecting lack of assembly of the primary components of elastic fibers [<xref ref-type="bibr" rid="fbln5-cutis-laxa.REF.ledouxcorbusier.1983.340">Ledoux-Corbusier 1983</xref>]. These findings are in contrast to those of Debr&#x000e9;-type cutis laxa (see <related-object link-type="booklink" source-id="gene" document-id="cutis-laxa" document-type="chapter"><italic toggle="yes">ATP6V0A2</italic>-Related Cutis Laxa</related-object>) and De Barsy syndrome (see <xref ref-type="sec" rid="fbln5-cutis-laxa.Differential_Diagnosis">Differential Diagnosis</xref>), in which a sparse elastic network, but not defective assembly of ELN fibers, is observed. Because deficiency of other proteins or cofactors involved in the process of elastic fiber assembly could potentially give the same ultrastructural picture, it is not known whether this feature is specific for <italic toggle="yes">FBLN5</italic>-related cutis laxa.Note: EM studies require a high level of expertise and are only available in specialized centers.</p>
            </list-item>
          </list>
          <sec id="fbln5-cutis-laxa.Molecular_Genetic_Testi">
            <title>Molecular Genetic Testing</title>
            <p><bold>Genes.</bold>
<italic toggle="yes">FBLN5</italic> (known previously as <italic toggle="yes">EVEC</italic> or <italic toggle="yes">DANCE</italic>) is the only gene in which pathogenic variants are known to cause <italic toggle="yes">FBLN5</italic>-related cutis laxa.</p>
            <p>
              <bold>Clinical testing</bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p><bold>Sequence analysis.</bold> To date, pathogenic variants have been identified in five families with autosomal recessive <italic toggle="yes">FBLN5</italic>-related cutis laxa through the use of sequence analysis.</p>
              </list-item>
            </list>
            <table-wrap id="fbln5-cutis-laxa.T.summary_of_molecular" position="anchor" orientation="portrait">
              <label>Table 1. </label>
              <caption>
                <p>Summary of Molecular Genetic Testing Used in <italic toggle="yes">FBLN5</italic>-Related Cutis Laxa</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_fbln5-cutis-laxa.T.summary_of_molecular_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                    <th id="hd_h_fbln5-cutis-laxa.T.summary_of_molecular_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                    <th id="hd_h_fbln5-cutis-laxa.T.summary_of_molecular_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of Probands with a Pathogenic Variant Detectable by This Method</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_fbln5-cutis-laxa.T.summary_of_molecular_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                      <italic toggle="yes">FBLN5</italic>
                    </td>
                    <td headers="hd_h_fbln5-cutis-laxa.T.summary_of_molecular_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>2</sup></td>
                    <td headers="hd_h_fbln5-cutis-laxa.T.summary_of_molecular_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;100%</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_fbln5-cutis-laxa.T.summary_of_molecular_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>3</sup></td>
                    <td headers="hd_h_fbln5-cutis-laxa.T.summary_of_molecular_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">See footnote 4</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="fbln5-cutis-laxa.TF.1.1">
                  <label>1. </label>
                  <p>See <related-object source-id="gene" document-id="fbln5-cutis-laxa" object-id="fbln5-cutis-laxa.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein. See <xref ref-type="sec" rid="fbln5-cutis-laxa.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants.</p>
                </fn>
                <fn id="fbln5-cutis-laxa.TF.1.2">
                  <label>2. </label>
                  <p>Sequence analysis detects variants that are benign, likely benign, of unknown significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
                </fn>
                <fn id="fbln5-cutis-laxa.TF.1.3">
                  <label>3. </label>
                  <p>Testing that identifies exon or whole-gene deletions/duplications not detectable by sequence analysis of the coding and flanking intronic regions of genomic DNA. Included in the variety of methods that may be used are: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray (CMA) that includes this gene/chromosome segment.</p>
                </fn>
                <fn id="fbln5-cutis-laxa.TF.1.4">
                  <label>4. </label>
                  <p>Duplication reported in one case of autosomal dominant disease [<xref ref-type="bibr" rid="fbln5-cutis-laxa.REF.markova.2003.998">Markova et al 2003</xref>]; see <xref ref-type="table" rid="fbln5-cutis-laxa.T.fbln5_variants">Table 3</xref>. No exon or whole-gene deletions or duplications are known to cause the autosomal recessive form of the disease.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </sec>
        </sec>
        <sec id="fbln5-cutis-laxa.Testing_Strategy">
          <title>Testing Strategy</title>
          <p>
            <bold>To confirm/establish the diagnosis in a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The diagnosis of <italic toggle="yes">FBLN5</italic>-related cutis laxa is established in individuals who meet clinical diagnostic criteria and have pathogenic variants identified in <italic toggle="yes">FBLN5</italic>.</p>
            </list-item>
            <list-item>
              <p>Molecular genetic testing begins with sequence analysis.</p>
            </list-item>
            <list-item>
              <p>If a pathogenic variant is not identified (or in the case of autosomal recessive <italic toggle="yes">FBLN5</italic>-related cutis laxa, if no or only one pathogenic variant is identified), deletion/duplication analysis is considered.</p>
            </list-item>
          </list>
          <p>
            <bold>Molecular genetic testing</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Single gene testing.</bold> One strategy for molecular diagnosis of a proband suspected of having <italic toggle="yes">FBLN5</italic>-related cutis laxa is sequence analysis of the gene.</p>
            </list-item>
            <list-item>
              <p><bold>Multi-gene panel.</bold> Another strategy for molecular diagnosis of a proband suspected of having <italic toggle="yes">FBLN5</italic>-related cutis laxa is use of a multi-gene panel. See <xref ref-type="sec" rid="fbln5-cutis-laxa.Differential_Diagnosis">Differential Diagnosis</xref>.</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec id="fbln5-cutis-laxa.Clinical_Characteristic">
        <title>Clinical Characteristics</title>
        <sec id="fbln5-cutis-laxa.Clinical_Description">
          <title>Clinical Description</title>
          <p>In addition to cutis laxa (the most common finding in <italic toggle="yes">FBLN5</italic>-related cutis laxa), most affected individuals have early childhood-onset pulmonary emphysema, peripheral pulmonary artery stenosis, and other evidence of a generalized connective disorder including inguinal hernias and hollow viscus diverticula (e.g., intestine, bladder). Occasionally, supravalvular aortic stenosis is observed. Intrafamilial variability in age of onset is observed.</p>
          <p>Infections secondary to vesicoureteral reflux (e.g., pyelonephritis) are observed. In one individual, the bladder was described on voiding cystouretrogram as having an unusual &#x0201c;cauliflower&#x0201d; shape secondary to the presence of multiple diverticula; a similar bladder appearance has been observed in individuals with <related-object link-type="booklink" source-id="gene" document-id="menkes" document-type="chapter">Menkes disease</related-object>.</p>
          <p>Pulmonary artery stenosis, congenital heart disease, and/or hollow viscus diverticula are likely to cause early death. Peripheral pulmonary artery stenoses lead to ventricular dilatation and contribute to progressive heart failure. Cardiorespiratory failure from complications of pulmonary emphysema (respiratory or cardiac insufficiency) is the most common cause of death. For those who survive early childhood, pulmonary emphysema, cor pulmonale, and multiple surgeries are the rule. Prolonged survival is exceptional; the oldest known person with this disorder was a high-functioning young woman who died at age 21 years from cor pulmonale.</p>
          <p>Hip dislocation is not observed in <italic toggle="yes">FBLN5</italic>-related cutis laxa.</p>
          <p>Intelligence is normal [<xref ref-type="bibr" rid="fbln5-cutis-laxa.REF.van_maldergem.1988.455">Van Maldergem et al 1988</xref>].</p>
          <p><bold>Autosomal recessive <italic toggle="yes">FBLN5</italic>-related cutis laxa</bold>. To date, five families with autosomal recessive <italic toggle="yes">FBLN5</italic>-related cutis laxa have been described [<xref ref-type="bibr" rid="fbln5-cutis-laxa.REF.van_maldergem.1988.455">Van Maldergem et al 1988</xref>, <xref ref-type="bibr" rid="fbln5-cutis-laxa.REF.karakurt.2001.422">Karakurt et al 2001</xref>, <xref ref-type="bibr" rid="fbln5-cutis-laxa.REF.loeys.2002.2113">Loeys et al 2002</xref>, <xref ref-type="bibr" rid="fbln5-cutis-laxa.REF.pourjafari.2004.87">Pour-Jafari &#x00026; Sahiri 2004</xref>, <xref ref-type="bibr" rid="fbln5-cutis-laxa.REF.claus.2008.1442">Claus et al 2008</xref>, <xref ref-type="bibr" rid="fbln5-cutis-laxa.REF.callewaert.2013.111">Callewaert et al 2013</xref>]. A listing of cases reported in the literature and fulfilling clinical criteria for <italic toggle="yes">FBLN5</italic>-related cutis laxa can be found in Appendix 1 of <xref ref-type="bibr" rid="fbln5-cutis-laxa.REF.van_maldergem.2008.1602">Van Maldergem et al [2008]</xref>.</p>
          <p>In the first family described, all six affected individuals had severe congenital cutis laxa and all but one had severe, variable pulmonary emphysema; the sixth was said to have normal chest x-rays. Ages of death ranged from six months to 21 years. Of note, the initial description of this family was expanded to include two relatives living in Western Europe and then a relative living in Turkey, who had initially been described as having Debr&#x000e9;-type cutis laxa [<xref ref-type="bibr" rid="fbln5-cutis-laxa.REF.karakurt.2001.422">Karakurt et al 2001</xref>]. The disorder in the latter individual was reclassified clinically as &#x0201c;pulmonary emphysema-type cutis laxa&#x0201d; based on his facial appearance in published photographs and then molecularly confirmed with identification of homozygosity for the same <italic toggle="yes">FBLN5</italic> base pair change (<xref ref-type="table" rid="fbln5-cutis-laxa.T.fbln5_variants">T998C</xref>) observed in the remainder of the family. Subsequent genealogic studies identified a common ancestor.</p>
          <p>In the second family, two affected children from an apparently unrelated family from Iran shared a similar clinical presentation plus supravalvular aortic stenosis. The children died at ages two years and 14 years. No common ancestor was found with the first family reported; however, homozygosity for the same base pair change (T998C) in these two children suggested identity by descent, which was supported by haplotype studies using polymorphic markers [<xref ref-type="bibr" rid="fbln5-cutis-laxa.REF.elahi.2006.1506">Elahi et al 2006</xref>].</p>
          <p>In a third family in which two children had cutis laxa, emphysema, and inguinal hernias, both children were alive at ages five and eight years [<xref ref-type="bibr" rid="fbln5-cutis-laxa.REF.claus.2008.1442">Claus et al 2008</xref>].</p>
          <p>Two additional families, one from Algeria and the other from Lebanon, each with three affected individuals, presented with similar phenotypes [<xref ref-type="bibr" rid="fbln5-cutis-laxa.REF.callewaert.2013.111">Callewaert et al 2013</xref>]. In the Algerian family, a homozygous <xref ref-type="table" rid="fbln5-cutis-laxa.T.fbln5_variants">c.1171G&#x0003e;T</xref> (p.Glu391Ter) pathogenic nonsense variant was observed, affecting the FBLN-specific domain, while in the Lebanese family, a <xref ref-type="table" rid="fbln5-cutis-laxa.T.fbln5_variants">c.649T&#x0003e;C</xref> homozygous missense variant, resulting in p.Cys217Arg residue change in the fourth cbEGF-like domain of the protein was observed. In the Lebanese family, all three affected siblings underwent surgery in the first months of life for pyloric stenosis; aortic valve dysplasia (stenosis and regurgitation) was reported in one affected child.</p>
          <p><bold>Heterozygous carriers for</bold>
<bold>autosomal recessive <italic toggle="yes">FBLN5</italic>-related cutis laxa</bold>. To date, no evidence has shown that heterozygous carriers in these families develop AMD.</p>
          <p><bold>Autosomal dominant</bold>
<bold><italic toggle="yes">FBLN5</italic>-related cutis laxa</bold>. Based on the description of the only family reported to date to have demonstrated autosomal dominant inheritance, this form appears to be milder in clinical presentation with less internal organ involvement than the autosomal recessive form [<xref ref-type="bibr" rid="fbln5-cutis-laxa.REF.markova.2003.998">Markova et al 2003</xref>].</p>
        </sec>
        <sec id="fbln5-cutis-laxa.GenotypePhenotype_Corre">
          <title>Genotype-Phenotype Correlations</title>
          <p>Mutation of <italic toggle="yes">FBLN5</italic> can cause either autosomal recessive or autosomal dominant cutis laxa resulting from alterations of the microfibrillar component of elastic fibers:</p>
          <list list-type="bullet">
            <list-item>
              <p>Recessive pathogenic variants entail loss of function resulting from aberrant folding and intracellular retention [<xref ref-type="bibr" rid="fbln5-cutis-laxa.REF.loeys.2002.2113">Loeys et al 2002</xref>].</p>
            </list-item>
            <list-item>
              <p>An affected individual from the only reported family with autosomal dominant inheritance had an elongated, stable protein that acted in a dominant-negative manner [<xref ref-type="bibr" rid="fbln5-cutis-laxa.REF.markova.2003.998">Markova et al 2003</xref>].</p>
            </list-item>
            <list-item>
              <p>One other individual who was heterozygous for an inherited <italic toggle="yes">FBLN5</italic> allele (<xref ref-type="table" rid="fbln5-cutis-laxa.T.fbln5_variants">p.Gly202Arg</xref>) and compound heterozygous for <italic toggle="yes">ELN</italic> alleles has been reported. It was hypothesized that the <italic toggle="yes">FBLN5</italic> allele modified the phenotype caused by the <italic toggle="yes">ELN</italic> pathogenic variants in the context of inflammatory destruction of elastic fibers in an acquired form of cutis laxa [<xref ref-type="bibr" rid="fbln5-cutis-laxa.REF.hu.2006.3379">Hu et al 2006</xref>].</p>
            </list-item>
          </list>
        </sec>
        <sec id="fbln5-cutis-laxa.Prevalence">
          <title>Prevalence</title>
          <p>The prevalence at birth for all types of cutis laxa is 1:4,000,000, according to the Rh&#x000f4;ne-Alpes Eurocat registry [E Robert, personal observation].</p>
        </sec>
      </sec>
      <sec id="fbln5-cutis-laxa.Genetically_Related_All">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>The only phenotype other than those discussed in this <italic toggle="yes">GeneReview</italic> that is known to be associated with pathogenic variants in <italic toggle="yes">FBLN5</italic> is age-related macular degeneration (AMD) [<xref ref-type="bibr" rid="fbln5-cutis-laxa.REF.stone.2004.346">Stone et al 2004</xref>].</p>
      </sec>
      <sec id="fbln5-cutis-laxa.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Other disorders characterized by cutis laxa are summarized in <xref ref-type="table" rid="fbln5-cutis-laxa.T.disorders_to_consider">Table 2</xref>.</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="efemp2-cutis-laxa" document-type="chapter"><bold><italic toggle="yes">FBLN4 </italic>(<italic toggle="yes">EFEMP2</italic>)-related cutis laxa</bold></related-object>
<bold>(ARCL1B).</bold>
<italic toggle="yes">EFEMP2-</italic>related cutis laxa (autosomal recessive cutis laxa type 1B [ARCL1B]) is characterized by cutis laxa and systemic involvement, most commonly arterial tortuosity, aneurysms, and stenosis; retrognathia; joint laxity; and arachnodactyly. Severity ranges from perinatal lethality as a result of cardiopulmonary failure to manifestations limited to the vascular and craniofacial systems. The cutis laxa and emphysema are similar in <italic toggle="yes">FBLN4</italic>- or <italic toggle="yes">FBLN5</italic>-related cutis laxa; however, to date, the diaphragmatic changes and arterial aneurysms seem more predominant in <italic toggle="yes">FBLN4</italic> (<italic toggle="yes">EFEMP2</italic>)<italic toggle="yes">-</italic>related cutis laxa.</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="cutis-laxa" document-type="chapter"><bold><italic toggle="yes">ATP6V0A2</italic>-related cutis laxa</bold></related-object>
<bold>(ARCL2A)</bold> spans a phenotypic spectrum that includes Debr&#x000e9;-type cutis laxa at the severe end and wrinkly skin syndrome at the mild end. Affected individuals have furrowing of the skin of the whole body that improves with time. They may have other evidence of a generalized connective disorder, including enlarged anterior fontanelle in infancy, congenital dislocation of the hips, inguinal hernias, and high myopia. In most, but not all, affected individuals, cortical and cerebellar malformations are present and are associated with severe developmental delays, seizures, and neurologic regression. Clinical features that distinguish <italic toggle="yes">FBLN5</italic>-related cutis laxa from ARCL2A are absence of intellectual disability, hip dislocation, and delayed closure of the fontanelle. In individuals with ARCL2A, EM findings of skin biopsy, rarefaction of ELN fibers composed of ELN and elastofibrils, and abnormal serum transferrin isoelectrofocusing (IEF) may help confirm the diagnosis.</p>
        <p><bold><italic toggle="yes">ELN</italic></bold>-<bold>related cutis laxa (ADCL)</bold> was historically considered a strictly cutaneous disorder without systemic involvement; however, it is now known that persons with <italic toggle="yes">ELN</italic> pathogenic variants can also have aortic aneurysms that require aortic root replacement or lead to aortic rupture in early adulthood. The aortic pathology of these aneurysms (so-called cystic media degeneration) is indistinguishable from that of <related-object link-type="booklink" source-id="gene" document-id="marfan" document-type="chapter">Marfan syndrome</related-object>. It remains to be seen whether <italic toggle="yes">ELN</italic> is mutated in persons with <related-object link-type="booklink" source-id="gene" document-id="taa" document-type="chapter">thoracic aortic aneurysms and aortic dissections</related-object> (TAAD) [<xref ref-type="bibr" rid="fbln5-cutis-laxa.REF.urban.2005.1193">Urban et al 2005</xref>].</p>
        <p><bold>Gerodermia osteodysplastica (GO).</bold> Onset occurs in infancy or early childhood [<xref ref-type="bibr" rid="fbln5-cutis-laxa.REF.nanda.2008.66">Nanda et al 2008</xref>]. Children appear older than their age as a result of sagging cheeks and jaw hypoplasia. Skin wrinkling is less severe and is confined to the dorsum of the hands and feet and to the abdomen when in the sitting position. A generalized connective tissue weakness leads to frequent hip dislocation and hernias. GO can be distinguished from other types of cutis laxa by the presence of osteopenia/osteoporosis and fractures, most commonly vertebral compression fractures, but also fractures of the long bones. Mental development is in the normal range. In contrast to Debr&#x000e9;-type cutis laxa, fontanelle size and closure are normal, positioning of the palpebral fissures is normal, and disease manifestations do not become milder with age. Mutation of <italic toggle="yes">SCYL1BP1</italic> is causative [<xref ref-type="bibr" rid="fbln5-cutis-laxa.REF.hennies.2008.1410">Hennies et al 2008</xref>].</p>
        <p><bold>De Barsy syndrome</bold> is characterized by a progeroid appearance, pre- and postnatal growth retardation, moderate to severe intellectual disability, corneal clouding or cataracts, and generalized cutis laxa [<xref ref-type="bibr" rid="fbln5-cutis-laxa.REF.guerra.2004.616">Guerra et al 2004</xref>]. The progeroid appearance is not caused by skin sagging, but rather by a hypoplasia of the dermis. Joint hyperlaxity, pseudoathetoid movements, and hyperreflexia are observed. Inheritance is autosomal recessive; with the exception of <italic toggle="yes">PYCR1</italic> (in which mutation accounts for a small percentage of De Barsy syndrome), the gene(s) associated with this disorder are not known.</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="ltbp4-cutis-laxa" document-type="chapter"><bold><italic toggle="yes">LTBP4</italic>-related cutis laxa</bold></related-object><bold>,</bold> first reported as a single case, is characterized by a cutaneous phenotype similar to that of <italic toggle="yes">FBLN5</italic>-related cutis laxa and by severe multiple malformations including congenital heart disease, pulmonary arterial stenosis and, interestingly, pulmonary hypertension. The latter appears to be a distinctive feature as it was observed in two patients in the authors&#x02019; series. Bladder diverticulae, noticeably absent in the other entities discussed in this section, have also been described.</p>
        <table-wrap id="fbln5-cutis-laxa.T.disorders_to_consider" position="anchor" orientation="portrait">
          <label>Table 2. </label>
          <caption>
            <p>Disorders to Consider in the Differential Diagnosis of Cutis Laxa</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_1" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_1">Disease Name</th>
                <th id="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_2" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_2">Gene</th>
                <th id="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_3" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_3">OMIM</th>
                <th id="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_4" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_4">MOI</th>
                <th id="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_5" valign="middle" colspan="5" align="left" scope="colgroup" rowspan="1">Clinical Findings</th>
              </tr>
              <tr>
                <th headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_5" id="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_2_1" valign="middle" colspan="1" align="left" scope="colgroup" rowspan="1">Cutis Laxa</th>
                <th headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_5" id="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Emphysema</th>
                <th headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_5" id="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_2_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Aneurysms</th>
                <th headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_5" id="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_2_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Intellectual Disability</th>
                <th headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_5" id="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_2_5" valign="middle" align="left" scope="col" rowspan="1" colspan="1">GI and GU Malformations</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">ARCL1A</td>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">FBLN5</italic>
                </td>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/219100">219100</ext-link>
                  <break/>
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/604580">604580</ext-link>
                </td>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">AR</td>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_5 hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">+++</td>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_5 hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">+++</td>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_5 hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">-</td>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_5 hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">-</td>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_5 hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">+</td>
              </tr>
              <tr>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">ARCL1B</td>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">EFEMP2</italic>
                </td>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/614437">614437</ext-link>
                  <break/>
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/604633">604633</ext-link>
                </td>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">AR</td>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_5 hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">++</td>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_5 hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">++</td>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_5 hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">+++</td>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_5 hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">-</td>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_5 hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">-</td>
              </tr>
              <tr>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1"><related-object link-type="booklink" source-id="gene" document-id="ltbp4-cutis-laxa" document-type="chapter">ARCL1C</related-object> (URDS)</td>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">LTBP4</italic>
                </td>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/613177">613177</ext-link>
                  <break/>
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/604710">604710</ext-link>
                </td>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">AR</td>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_5 hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">++</td>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_5 hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">+++</td>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_5 hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">-</td>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_5 hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">-</td>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_5 hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">+++</td>
              </tr>
              <tr>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">ARCL2A</td>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">ATP6V0A2</italic>
                </td>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/278250">278250</ext-link>
                  <break/>
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/219200">219200</ext-link>
                </td>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">AR</td>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_5 hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">++</td>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_5 hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">-</td>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_5 hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">-</td>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_5 hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">++</td>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_5 hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">-</td>
              </tr>
              <tr>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">ARCL2B</td>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">PYCR1</italic>
                </td>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/612940">612940</ext-link>
                  <break/>
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/614438">614438</ext-link>
                  <break/>
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/179035">179035</ext-link>
                </td>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">AR</td>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_5 hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">++</td>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_5 hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_5 hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">-</td>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_5 hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">++</td>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_5 hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">-</td>
              </tr>
              <tr>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">ADCL</td>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1"><italic toggle="yes">ELN</italic> or <italic toggle="yes">FBLN5</italic></td>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/123700">123700</ext-link>
                  <break/>
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/130160">130160</ext-link>
                  <break/>
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/604580">604580</ext-link>
                </td>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">AD</td>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_5 hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_5 hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_5 hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_5 hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">-</td>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_5 hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">-</td>
              </tr>
              <tr>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">GO</td>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">SCYL1BP1</italic>
                </td>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/231070">231070</ext-link>
                </td>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">AR</td>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_5 hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">+ +</td>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_5 hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">-</td>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_5 hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">-</td>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_5 hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">-</td>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_5 hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">-</td>
              </tr>
              <tr>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">De Barsy syndrome</td>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1"><italic toggle="yes">PYCR1</italic>&#x000a0;<sup>1</sup></td>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/219150">219150</ext-link>
                </td>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">AR</td>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_5 hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">+</td>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_5 hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">-</td>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_5 hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">-</td>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_5 hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">+++</td>
                <td headers="hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_1_5 hd_h_fbln5-cutis-laxa.T.disorders_to_consider_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">-</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>MOI = mode of inheritance</p>
            </fn>
            <fn id="fbln5-cutis-laxa.TF.2.1">
              <label>1. </label>
              <p>Pathogenic variants in <italic toggle="yes">PYCR1</italic> account for a small percentage of De Barsy syndrome.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec id="fbln5-cutis-laxa.Management">
        <title>Management</title>
        <sec id="fbln5-cutis-laxa.Evaluations_Following_I">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with <italic toggle="yes">FBLN5</italic>-related cutis laxa, the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Chest roentgenogram</p>
            </list-item>
            <list-item>
              <p>Echocardiogram</p>
            </list-item>
            <list-item>
              <p>Kidney ultrasound examination</p>
            </list-item>
            <list-item>
              <p>Medical genetics consultation</p>
            </list-item>
          </list>
          <p>If clinically indicated:</p>
          <list list-type="bullet">
            <list-item>
              <p>Pulmonary vessel angiogram</p>
            </list-item>
            <list-item>
              <p>Barium enema</p>
            </list-item>
            <list-item>
              <p>Voiding cystouretrogram (VCUG)</p>
            </list-item>
          </list>
        </sec>
        <sec id="fbln5-cutis-laxa.Treatment_of_Manifestat">
          <title>Treatment of Manifestations</title>
          <p>Appropriate treatment for:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Inguinal hernias.</bold> Routine repair</p>
            </list-item>
            <list-item>
              <p><bold>Cutis laxa.</bold> Repeat plastic surgery of the face and trunk as needed</p>
            </list-item>
            <list-item>
              <p><bold>Pulmonary emphysema.</bold> Symptomatic treatment</p>
            </list-item>
            <list-item>
              <p><bold>Arterial abnormalities.</bold> No treatment available</p>
            </list-item>
          </list>
        </sec>
        <sec id="fbln5-cutis-laxa.Prevention_of_Secondary">
          <title>Prevention of Secondary Complications</title>
          <p>The following are appropriate:</p>
          <list list-type="bullet">
            <list-item>
              <p>Attention to respiratory function prior to surgery</p>
            </list-item>
            <list-item>
              <p>Prophylactic antibiotics (cotrimoxazole) in case of vesicoureteral reflux</p>
            </list-item>
          </list>
        </sec>
        <sec id="fbln5-cutis-laxa.Surveillance">
          <title>Surveillance</title>
          <p>Routine surveillance of the urinary tract for evidence of bladder diverticula and/or vesicoureteral reflux is indicated.</p>
        </sec>
        <sec id="fbln5-cutis-laxa.AgentsCircumstances_to">
          <title>Agents/Circumstances to Avoid</title>
          <p>Smoking is contraindicated; however, the limited life span of affected individuals makes this recommendation mostly theoretic.</p>
        </sec>
        <sec id="fbln5-cutis-laxa.Evaluation_of_Relatives">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="fbln5-cutis-laxa.Related_Genetic_Counsel">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="fbln5-cutis-laxa.Therapies_Under_Investi">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="fbln5-cutis-laxa.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="fbln5-cutis-laxa.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p><italic toggle="yes">FBLN5</italic>-related cutis laxa can be inherited in an autosomal recessive or autosomal dominant manner. Autosomal recessive inheritance is more common.</p>
        </sec>
        <sec id="fbln5-cutis-laxa.Risk_to_Family_Members">
          <title>Risk to Family Members &#x02013; Autosomal Recessive Inheritance</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The parents of an affected child are obligate heterozygotes and therefore carry one mutant allele.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier.</p>
            </list-item>
            <list-item>
              <p>Once an at-risk sib is known to be unaffected, the risk of his/her being a carrier is 2/3.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Individuals with autosomal recessive <italic toggle="yes">FBLN5</italic>-related cutis laxa have not been reported to reproduce. If they were to reproduce, their offspring would be obligate heterozygotes (carriers) for a pathogenic variant.</p>
          <p><bold>Other family members of a proband.</bold> Each sib of the proband&#x02019;s parents is at a 50% risk of being a carrier.</p>
        </sec>
        <sec id="fbln5-cutis-laxa.Carrier_Detection">
          <title>Carrier Detection</title>
          <p>Carrier testing of at-risk relatives is possible if the pathogenic <italic toggle="yes">FBLN5</italic> variants have been identified in the family.</p>
        </sec>
        <sec id="fbln5-cutis-laxa.Risk_to_Family_Members_1">
          <title>Risk to Family Members &#x02013; Autosomal Dominant Inheritance</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Rare individuals diagnosed with autosomal dominant <italic toggle="yes">FBLN5</italic>-related cutis laxa have an affected parent.</p>
            </list-item>
            <list-item>
              <p>A proband with autosomal dominant <italic toggle="yes">FBLN5</italic>-related cutis laxa may have the disorder as the result of a <italic toggle="yes">de novo</italic> pathogenic variant. The proportion of cases caused by a <italic toggle="yes">de novo</italic> pathogenic variant is unknown</p>
            </list-item>
            <list-item>
              <p>Recommendations for the evaluation of parents of a proband with an apparent <italic toggle="yes">de novo</italic> pathogenic variant include a dermatologic examination and molecular genetic testing for the pathogenic variant identified in the proband. Evaluation of parents may determine that one is affected but has escaped previous diagnosis because of a milder phenotypic presentation. Therefore, an apparently negative family history cannot be confirmed until appropriate evaluations have been performed.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to the sibs of the proband depends on the genetic status of the proband&#x02019;s parents.</p>
            </list-item>
            <list-item>
              <p>If a parent of the proband is affected, the risk to the sibs is 50%.</p>
            </list-item>
            <list-item>
              <p>When the parents are clinically unaffected, the risk to the sibs of a proband appears to be low.</p>
            </list-item>
            <list-item>
              <p>The sibs of a proband with clinically unaffected parents are still at increased risk for the disorder because of the possibility of reduced penetrance in a parent.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Each child of an individual with autosomal dominant cutis laxa has a 50% chance of inheriting the pathogenic variant.</p>
          <p><bold>Other family members of a proband.</bold> The risk to other family members depends on the status of the proband's parents. If a parent is affected, his or her family members may be at risk.</p>
        </sec>
        <sec id="fbln5-cutis-laxa.Related_Genetic_Counsel">
          <title>Related Genetic Counseling Issues</title>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected, are carriers, or are at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="fbln5-cutis-laxa.Prenatal_Testing_and_Pr">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the <italic toggle="yes">FBLN5</italic> pathogenic variant(s) have been identified in an affected family member, prenatal testing and preimplantation genetic diagnosis for a pregnancy at increased risk for <italic toggle="yes">FBLN5</italic>-related cutis laxa are possible options.</p>
        </sec>
      </sec>
      <sec id="fbln5-cutis-laxa.Resources">
        <title>Resources</title>
      </sec>
      <sec id="fbln5-cutis-laxa.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="fbln5-cutis-laxa.Molecular_Genetic_Patho">
          <title>Molecular Genetic Pathogenesis</title>
          <p>Independent of the underlying molecular pathophysiology, all types of cutis laxa are characterized by alterations of elastic fibers, not collagen. In ultrastructural investigations elastic fibers are reduced in number and often appear fragmented.</p>
          <p>The assembly of elastic fibers, a complex mechanism, takes place in the extracellular space. According to the currently accepted model, microfibrillar proteins like the fibrillins first form a lattice with fibulins into which secreted tropoelastin is deposited and then further processed [<xref ref-type="bibr" rid="fbln5-cutis-laxa.REF.kielty.2006.1">Kielty 2006</xref>]. Enzymes necessary for the conversion of tropoelastin into ELN are the lysyl oxidases, a group of copper-dependent enzymes (deficient in secondary cutis laxa associated with treatment with copper chelators like penicillamine) which form covalent crosslinks between ELN molecules. Elastic fibers not only increase the elasticity of the extracellular matrix, but also influence its architecture and regulate TGF&#x003b2;-signaling.</p>
          <p>When tropoelastin expression is insufficient, the generation of elastic fibers is disturbed. This explains why heterozygous loss-of-function <italic toggle="yes">ELN</italic> pathogenic variants cause alterations that primarily affect the vasculature (supravalvular aortic stenosis) and only minimally affect the skin. In autosomal dominant cutis laxa, <italic toggle="yes">ELN</italic> pathogenic variants are mostly confined to the 3&#x02019; end of the gene [<xref ref-type="bibr" rid="fbln5-cutis-laxa.REF.metcalfe.2000.955">Metcalfe et al 2000</xref>]. These variants result in secretion of abnormal tropoelastin molecules that interfere with elastic fiber assembly in a dominant-negative fashion [<xref ref-type="bibr" rid="fbln5-cutis-laxa.REF.zhang.1999.981">Zhang et al 1999</xref>].</p>
          <p>Pathogenic variants in <italic toggle="yes">FBLN5</italic> can cause either dominant or recessive cutis laxa resulting from alterations of the microfibrillar component of the elastic fibers. The dominant pathogenic variants lead to an elongation of the protein that is stable and can act in a dominant-negative manner [<xref ref-type="bibr" rid="fbln5-cutis-laxa.REF.markova.2003.998">Markova et al 2003</xref>], whereas the recessive pathogenic variants entail loss of function as a result of aberrant folding and intracellular retention [<xref ref-type="bibr" rid="fbln5-cutis-laxa.REF.loeys.2002.2113">Loeys et al 2002</xref>, <xref ref-type="bibr" rid="fbln5-cutis-laxa.REF.hu.2006.3379">Hu et al 2006</xref>]. The same applies to recessive pathogenic variants in <italic toggle="yes">FBLN4</italic> (<italic toggle="yes">EFEMP2</italic>) [<xref ref-type="bibr" rid="fbln5-cutis-laxa.REF.hucthagowder.2006.1075">Hucthagowder et al 2006</xref>] (see <related-object link-type="booklink" source-id="gene" document-id="efemp2-cutis-laxa" document-type="chapter"><italic toggle="yes">EFEMP2</italic>-Related Cutis Laxa</related-object>).</p>
          <p>A more complex mechanism underlies autosomal recessive cutis laxa, Debr&#x000e9; type (ARCL2A) (see <related-object link-type="booklink" source-id="gene" document-id="cutis-laxa" document-type="chapter"><italic toggle="yes">ATP6V0A2</italic>-Related Cutis Laxa</related-object>). Here, the loss-of-function variants do not affect an extracellular matrix protein, but a subunit of a v-type H<sup>+</sup>-ATPase that resides in endosomes as well as in the Golgi compartment [<xref ref-type="bibr" rid="fbln5-cutis-laxa.REF.hurtadolorenzo.2006.124">Hurtado-Lorenzo et al 2006</xref>, <xref ref-type="bibr" rid="fbln5-cutis-laxa.REF.pietrement.2006.185">Pietrement et al 2006</xref>]. Proton pumps are universally expressed and allow pH regulation in the extracellular space and in many subcellular compartments [<xref ref-type="bibr" rid="fbln5-cutis-laxa.REF.forgac.2007.917">Forgac 2007</xref>]. In addition, there are indications that a subunit of the proton pump complex is directly involved in vesicle fusion [<xref ref-type="bibr" rid="fbln5-cutis-laxa.REF.peters.2001.581">Peters et al 2001</xref>]. The following two lines of evidence suggest that a defect of the secretory pathway is the basis of the elastic fiber defect in ARCL2A:</p>
          <list list-type="bullet">
            <list-item>
              <p>Patients show a glycosylation defect, which can be detected by isoelectrofocusing (IEF) of serum transferrins [<xref ref-type="bibr" rid="fbln5-cutis-laxa.REF.morava.2005.414">Morava et al 2005</xref>, <xref ref-type="bibr" rid="fbln5-cutis-laxa.REF.kornak.2008.32">Kornak et al 2008</xref>, <xref ref-type="bibr" rid="fbln5-cutis-laxa.REF.van_maldergem.2008.1602">Van Maldergem et al 2008</xref>].</p>
            </list-item>
            <list-item>
              <p>Patient cells display a delay of Golgi-to-ER trafficking. It is unknown whether the glycosylation defect impairs the function of a protein involved in the formation of elastic fibers or if it is just an epiphenomenon caused by a secretion defect also involving elastic fiber components.</p>
            </list-item>
          </list>
          <p><bold>Gene structure.</bold>
<italic toggle="yes">FBLN5</italic> consists of 13 exons that are differentially combined in three major transcripts. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="fbln5-cutis-laxa" object-id="fbln5-cutis-laxa.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
          <p><bold>Benign allelic variants.</bold> See <xref ref-type="table" rid="fbln5-cutis-laxa.T.fbln5_variants">Table 3</xref>. The only annotated nonsynonymous coding normal variant in <italic toggle="yes">FBLN5</italic> resides in exon 10 and leads to a p.Asp364Tyr change.</p>
          <p><bold>Pathogenic allelic variants.</bold> See <xref ref-type="table" rid="fbln5-cutis-laxa.T.fbln5_variants">Table 3</xref>.</p>
          <list list-type="bullet">
            <list-item>
              <p>Autosomal recessive <italic toggle="yes">FBLN5</italic>-related cutis laxa: p.Cys217Arg (in 2 families), p.Ser227Pro (in 2 likely related families), p.Gly202Arg, and p.Glu391Ter [Loeys, personal communication]</p>
            </list-item>
            <list-item>
              <p>Autosomal dominant <italic toggle="yes">FBLN5</italic>-related cutis laxa: a 22,729-bp duplication comprising all of exons 5 to 8 and the first 9 bp of exon 9 [<xref ref-type="bibr" rid="fbln5-cutis-laxa.REF.markova.2003.998">Markova et al 2003</xref>]</p>
            </list-item>
          </list>
          <table-wrap id="fbln5-cutis-laxa.T.fbln5_variants" position="anchor" orientation="portrait">
            <label>Table 3. </label>
            <caption>
              <p><italic toggle="yes">FBLN5</italic> Variants</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_fbln5-cutis-laxa.T.fbln5_variants_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Variant Classification</th>
                  <th id="hd_h_fbln5-cutis-laxa.T.fbln5_variants_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change (Alias&#x000a0;<sup>1</sup>)</th>
                  <th id="hd_h_fbln5-cutis-laxa.T.fbln5_variants_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Protein Amino Acid Change</th>
                  <th id="hd_h_fbln5-cutis-laxa.T.fbln5_variants_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_fbln5-cutis-laxa.T.fbln5_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Benign</bold>
                  </td>
                  <td headers="hd_h_fbln5-cutis-laxa.T.fbln5_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.1090G&#x0003e;T&#x000a0;<sup>2</sup></td>
                  <td headers="hd_h_fbln5-cutis-laxa.T.fbln5_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Asp364Tyr</td>
                  <td headers="hd_h_fbln5-cutis-laxa.T.fbln5_variants_1_1_1_4" rowspan="6" valign="middle" align="left" colspan="1">
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/186928842">NM_006329.3</ext-link>
                    <break/>
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/19743803">NP_006320.2</ext-link>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_fbln5-cutis-laxa.T.fbln5_variants_1_1_1_1" rowspan="5" valign="middle" align="left" scope="row" colspan="1">
                    <bold>Pathogenic</bold>
                  </td>
                  <td headers="hd_h_fbln5-cutis-laxa.T.fbln5_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.604G&#x0003e;A</td>
                  <td headers="hd_h_fbln5-cutis-laxa.T.fbln5_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Gly202Arg</td>
                </tr>
                <tr>
                  <td headers="hd_h_fbln5-cutis-laxa.T.fbln5_variants_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.649T&#x0003e;C</td>
                  <td headers="hd_h_fbln5-cutis-laxa.T.fbln5_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Cys217Arg</td>
                </tr>
                <tr>
                  <td headers="hd_h_fbln5-cutis-laxa.T.fbln5_variants_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.679T&#x0003e;C<break/>(T998C)</td>
                  <td headers="hd_h_fbln5-cutis-laxa.T.fbln5_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Ser227Pro</td>
                </tr>
                <tr>
                  <td headers="hd_h_fbln5-cutis-laxa.T.fbln5_variants_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.1171G&#x0003e;T</td>
                  <td headers="hd_h_fbln5-cutis-laxa.T.fbln5_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Glu391Ter</td>
                </tr>
                <tr>
                  <td headers="hd_h_fbln5-cutis-laxa.T.fbln5_variants_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">(380-9063_872dup22729)&#x000a0;<sup>3</sup></td>
                  <td headers="hd_h_fbln5-cutis-laxa.T.fbln5_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">See footnote 4</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
              </fn>
              <fn>
                <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
              </fn>
              <fn id="fbln5-cutis-laxa.TF.3.1">
                <label>1. </label>
                <p>Variant designation that does not conform to current naming conventions</p>
              </fn>
              <fn id="fbln5-cutis-laxa.TF.3.2">
                <label>2. </label>
                <p>
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1802492">rs1802492</ext-link>
                </p>
              </fn>
              <fn id="fbln5-cutis-laxa.TF.3.3">
                <label>3. </label>
                <p>Duplication of 22,729 nucleotides from intron 4 to exon 9 [<xref ref-type="bibr" rid="fbln5-cutis-laxa.REF.markova.2003.998">Markova et al 2003</xref>]</p>
              </fn>
              <fn id="fbln5-cutis-laxa.TF.3.4">
                <label>4. </label>
                <p>Duplication results in a tandem duplication of 483 nucleotides in the transcript resulting in tandem duplication of four cbEGF motifs in the protein product [<xref ref-type="bibr" rid="fbln5-cutis-laxa.REF.markova.2003.998">Markova et al 2003</xref>]. The only pathogenic variant known to cause the autosomal dominant form of the disease.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Normal gene product.</bold> Fibulin-5, the protein encoded by <italic toggle="yes">FBLN5</italic>, is an extracellular matrix protein involved in the formation of the microfibrillar scaffold of the elastic fibers. It contains calcium-binding EGF-like repeats and an RGD-motif and is approximately 55 kd in size. The same applies to fibulin-4, encoded by <italic toggle="yes">FBLN4</italic> (<italic toggle="yes">EFEMP2</italic>), except that fibulin-4 does not contain an RGD-motif.</p>
          <p><bold>Abnormal gene product.</bold> Autosomal recessive variants in <italic toggle="yes">FBLN5</italic> result in intracellular retention of the misfolded protein [<xref ref-type="bibr" rid="fbln5-cutis-laxa.REF.hu.2006.3379">Hu et al 2006</xref>], resulting in a loss of function. Autosomal dominant variants lead to an elongation of the protein that is stable and can act in a dominant-negative manner [<xref ref-type="bibr" rid="fbln5-cutis-laxa.REF.markova.2003.998">Markova et al 2003</xref>].</p>
        </sec>
      </sec>
      <sec id="fbln5-cutis-laxa.References">
        <title>References</title>
        <sec id="fbln5-cutis-laxa.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="fbln5-cutis-laxa.Literature_Cited.reflist0">
            <ref id="fbln5-cutis-laxa.REF.callewaert.2013.111">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Callewaert</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Su</surname>
                    <given-names>CT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Damme</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vlummens</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malfait</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanakker</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schulz</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mac Neal</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davis</surname>
                    <given-names>EC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>JG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salhi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Unger</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heimdal</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Almeida</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kornak</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gaspar</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bresson</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prescott</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gosendi</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mansour</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pi&#x000e9;rard</surname>
                    <given-names>GE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Madan-Khetarpal</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sciurba</surname>
                    <given-names>FC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Symoens</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coucke</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Maldergem</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Urban</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Paepe</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Comprehensive clinical and molecular analysis of 12 families with type 1 recessive cutis laxa.</article-title>
                <source>Hum Mutat.</source>
                <year>2013</year>
                <volume>34</volume>
                <fpage>111</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">22829427</pub-id>
              </element-citation>
            </ref>
            <ref id="fbln5-cutis-laxa.REF.claus.2008.1442">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Claus</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fischer</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000e9;garban&#x000e9;</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000e9;garban&#x000e9;</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jobard</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Debret</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peyrol</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saker</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Devillers</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sommer</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Damour</surname>
                    <given-names>O</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>A p.C217R mutation in fibulin-5 from cutis laxa patients is associated with incomplete extracellular matrix formation in a skin equivalent model.</article-title>
                <source>J Invest Dermatol</source>
                <volume>128</volume>
                <fpage>1442</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">18185537</pub-id>
              </element-citation>
            </ref>
            <ref id="fbln5-cutis-laxa.REF.elahi.2006.1506">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Elahi</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalhor</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Banihosseini</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Torabi</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pour-Jafari</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Houshmand</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amini</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramezani</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loeys</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Homozygous missense mutation in fibulin-5 in an Iranian autosomal recessive cutis laxa pedigree and associated haplotype.</article-title>
                <source>J Invest Dermatol</source>
                <volume>126</volume>
                <fpage>1506</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">16691202</pub-id>
              </element-citation>
            </ref>
            <ref id="fbln5-cutis-laxa.REF.forgac.2007.917">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Forgac</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Vacuolar ATPases: rotary proton pumps in physiology and pathophysiology.</article-title>
                <source>Nat Rev Mol Cell Biol</source>
                <volume>8</volume>
                <fpage>917</fpage>
                <lpage>29</lpage>
                <pub-id pub-id-type="pmid">17912264</pub-id>
              </element-citation>
            </ref>
            <ref id="fbln5-cutis-laxa.REF.guerra.2004.616">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Guerra</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fornieri</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bacchelli</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lugli</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Balli</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrari</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>The de Barsy syndrome.</article-title>
                <source>J Cutan Pathol</source>
                <volume>31</volume>
                <fpage>616</fpage>
                <lpage>24</lpage>
                <pub-id pub-id-type="pmid">15330994</pub-id>
              </element-citation>
            </ref>
            <ref id="fbln5-cutis-laxa.REF.hennies.2008.1410">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hennies</surname>
                    <given-names>HC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kornak</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Egerer</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seifert</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>K&#x000fc;hnisch</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Budde</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>N&#x000e4;tebus</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brancati</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilcox</surname>
                    <given-names>WR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000fc;ller</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaplan</surname>
                    <given-names>PB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rajab</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zampino</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fodale</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dallapiccola</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Newman</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Metcalfe</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clayton-Smith</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tassabehji</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinmann</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barr</surname>
                    <given-names>FA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>N&#x000fc;rnberg</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wieacker</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mundlos</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Gerodermia osteodysplastica is caused by mutations in SCYL1BP1, a Rab-6 interacting golgin.</article-title>
                <source>Nat Genet</source>
                <volume>40</volume>
                <fpage>1410</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">18997784</pub-id>
              </element-citation>
            </ref>
            <ref id="fbln5-cutis-laxa.REF.hu.2006.3379">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hu</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loeys</surname>
                    <given-names>BL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coucke</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Paepe</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mecham</surname>
                    <given-names>RP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Choi</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davis</surname>
                    <given-names>EC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Urban</surname>
                    <given-names>Z</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Fibulin-5 mutations: mechanisms of impaired elastic fiber formation in recessive cutis laxa.</article-title>
                <source>Hum Mol Genet</source>
                <volume>15</volume>
                <fpage>3379</fpage>
                <lpage>86</lpage>
                <pub-id pub-id-type="pmid">17035250</pub-id>
              </element-citation>
            </ref>
            <ref id="fbln5-cutis-laxa.REF.hucthagowder.2006.1075">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hucthagowder</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sausgruber</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Angle</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marmorstein</surname>
                    <given-names>LY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Urban</surname>
                    <given-names>Z</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Fibulin-4: a novel gene for an autosomal recessive cutis laxa syndrome.</article-title>
                <source>Am J Hum Genet</source>
                <volume>78</volume>
                <fpage>1075</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">16685658</pub-id>
              </element-citation>
            </ref>
            <ref id="fbln5-cutis-laxa.REF.hurtadolorenzo.2006.124">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hurtado-Lorenzo</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Skinner</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>El Annan</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Futai</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sun-Wada</surname>
                    <given-names>GH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bourgoin</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Casanova</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wildeman</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bechoua</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ausiello</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marshansky</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>V-ATPase interacts with ARNO and Arf6 in early endosomes and regulates the protein degradative pathway.</article-title>
                <source>Nat Cell Biol</source>
                <volume>8</volume>
                <fpage>124</fpage>
                <lpage>36</lpage>
                <pub-id pub-id-type="pmid">16415858</pub-id>
              </element-citation>
            </ref>
            <ref id="fbln5-cutis-laxa.REF.karakurt.2001.422">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Karakurt</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sipahi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ceylaner</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Senocak</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karademir</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Becer</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Cutis laxa with growth and developmental delay.</article-title>
                <source>Clin Pediatr (Phila)</source>
                <volume>40</volume>
                <fpage>422</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">11491141</pub-id>
              </element-citation>
            </ref>
            <ref id="fbln5-cutis-laxa.REF.kielty.2006.1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kielty</surname>
                    <given-names>CM</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Elastic fibres in health and disease.</article-title>
                <source>Expert Rev Mol Med</source>
                <volume>8</volume>
                <fpage>1</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">16893474</pub-id>
              </element-citation>
            </ref>
            <ref id="fbln5-cutis-laxa.REF.kornak.2008.32">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kornak</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reynders</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dimopoulou</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Reeuwijk</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fischer</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rajab</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Budde</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>N&#x000fc;rnberg</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Foulquier</surname>
                    <given-names>F</given-names>
                  </name>
                  <collab>ARCL Debr&#x000e9;-type Study Group</collab>
                </person-group>
                <article-title>Lefeber D, Urban Z, Gruenewald S, Annaert W, Brunner HG, van Bokhoven H, Wevers R, Morava E, Matthijs G, Van Maldergem L, Mundlos S. Impaired glycosylation and cutis laxa caused by mutations in the vesicular H+-ATPase subunit ATP6V0A2.</article-title>
                <source>Nat Genet.</source>
                <year>2008</year>
                <month>Jan</month>
                <volume>40</volume>
                <issue>1</issue>
                <fpage>32</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">18157129</pub-id>
              </element-citation>
            </ref>
            <ref id="fbln5-cutis-laxa.REF.ledouxcorbusier.1983.340">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ledoux-Corbusier</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>1983</year>
                <article-title>Cutis laxa: congenital form with pulmonary emphysema. An ultrastructural study.</article-title>
                <source>J Cutan Pathol</source>
                <volume>10</volume>
                <fpage>340</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">6630666</pub-id>
              </element-citation>
            </ref>
            <ref id="fbln5-cutis-laxa.REF.loeys.2002.2113">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Loeys</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Maldergem</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mortier</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coucke</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gerniers</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naeyaert</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Paepe</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Homozygosity for a missense mutation in fibulin-5 (FBLN5) results in a severe form of cutis laxa.</article-title>
                <source>Hum Mol Genet</source>
                <volume>11</volume>
                <fpage>2113</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">12189163</pub-id>
              </element-citation>
            </ref>
            <ref id="fbln5-cutis-laxa.REF.markova.2003.998">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Markova</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zou</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ringpfeil</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sasaki</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kostka</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Timpl</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitto</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chu</surname>
                    <given-names>ML</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Genetic heterogeneity of cutis laxa: a heterozygous tandem duplication within the fibulin-5 (FBLN5) gene.</article-title>
                <source>Am J Hum Genet</source>
                <volume>72</volume>
                <fpage>998</fpage>
                <lpage>1004</lpage>
                <pub-id pub-id-type="pmid">12618961</pub-id>
              </element-citation>
            </ref>
            <ref id="fbln5-cutis-laxa.REF.metcalfe.2000.955">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Metcalfe</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rucka</surname>
                    <given-names>AK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smoot</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hofstadler</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tuzler</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McKeown</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siu</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rauch</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dean</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dennis</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellis</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reardon</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cytrynbaum</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Osborne</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yates</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Read</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Donnai</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tassabehji</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Elastin: mutational spectrum in supravalvular aortic stenosis.</article-title>
                <source>Eur J Hum Genet</source>
                <volume>8</volume>
                <fpage>955</fpage>
                <lpage>63</lpage>
                <pub-id pub-id-type="pmid">11175284</pub-id>
              </element-citation>
            </ref>
            <ref id="fbln5-cutis-laxa.REF.morava.2005.414">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Morava</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wopereis</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coucke</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gillessen-Kasbach</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Voit</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smeitink</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wevers</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gr&#x000fc;newald</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Defective protein glycosylation in patients with cutis laxa syndrome.</article-title>
                <source>Eur J Hum Genet</source>
                <volume>13</volume>
                <fpage>414</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">15657616</pub-id>
              </element-citation>
            </ref>
            <ref id="fbln5-cutis-laxa.REF.nanda.2008.66">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nanda</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alsaleh</surname>
                    <given-names>QA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Sabah</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marzouk</surname>
                    <given-names>EE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salam</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nanda</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anim</surname>
                    <given-names>JT</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Geroderma osteodysplastica/ wrinkly skin syndrome: report of three patients and brief review of the literature.</article-title>
                <source>Pediatr Dermatol</source>
                <volume>25</volume>
                <fpage>66</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">18304158</pub-id>
              </element-citation>
            </ref>
            <ref id="fbln5-cutis-laxa.REF.peters.2001.581">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Peters</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bayer</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>B&#x000fc;hler</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andersen</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mann</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mayer</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Trans-complex formation by proteolipid channels in the terminal phase of membrane fusion.</article-title>
                <source>Nature</source>
                <volume>409</volume>
                <fpage>581</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">11214310</pub-id>
              </element-citation>
            </ref>
            <ref id="fbln5-cutis-laxa.REF.pietrement.2006.185">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pietrement</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sun-Wada</surname>
                    <given-names>GH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Silva</surname>
                    <given-names>ND</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McKee</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marshansky</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Futai</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Breton</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Distinct expression patterns of different subunit isoforms of the V-ATPase in the rat epididymis.</article-title>
                <source>Biol Reprod</source>
                <volume>74</volume>
                <fpage>185</fpage>
                <lpage>94</lpage>
                <pub-id pub-id-type="pmid">16192400</pub-id>
              </element-citation>
            </ref>
            <ref id="fbln5-cutis-laxa.REF.pourjafari.2004.87">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pour-Jafari</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sahiri</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Presentation of a pedigree of an Iranian family with two members with autosomal recessive cutis laxa type 1.</article-title>
                <source>Med J Islam Repub Ir</source>
                <volume>18</volume>
                <fpage>87</fpage>
                <lpage>9</lpage>
              </element-citation>
            </ref>
            <ref id="fbln5-cutis-laxa.REF.stone.2004.346">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Stone</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Braun</surname>
                    <given-names>TA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Russell</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuehn</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lotery</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moore</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eastman</surname>
                    <given-names>CG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Casavant</surname>
                    <given-names>TL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sheffield</surname>
                    <given-names>VC</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Missense variations in the fibulin 5 gene and age-related macular degeneration.</article-title>
                <source>N Engl J Med</source>
                <volume>351</volume>
                <fpage>346</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">15269314</pub-id>
              </element-citation>
            </ref>
            <ref id="fbln5-cutis-laxa.REF.urban.2005.1193">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Urban</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gao</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pope</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davis</surname>
                    <given-names>EC</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Autosomal dominant cutis laxa with severe lung disease: synthesis and matrix deposition of mutant tropoelastin.</article-title>
                <source>J Invest Dermatol</source>
                <volume>124</volume>
                <fpage>1193</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">15955094</pub-id>
              </element-citation>
            </ref>
            <ref id="fbln5-cutis-laxa.REF.van_maldergem.1988.455">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Van Maldergem</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vamos</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liebaers</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petit</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vandevelde</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simonis-Blumenfrucht</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bouffioux</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kulakowski</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanquinet</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Durme</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laporte</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ledoux-Corbusier</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reynolds</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neri</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>1988</year>
                <article-title>Severe congenital cutis laxa with pulmonary emphysema: a family with three affected sibs.</article-title>
                <source>Am J Med Genet</source>
                <volume>31</volume>
                <fpage>455</fpage>
                <lpage>64</lpage>
                <pub-id pub-id-type="pmid">3232707</pub-id>
              </element-citation>
            </ref>
            <ref id="fbln5-cutis-laxa.REF.van_maldergem.2008.1602">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Van Maldergem</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yuksel-Apak</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kayserili</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seemanova</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giurgea</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Basel-Vanagaite</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leao-Teles</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vigneron</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Foulon</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greally</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jaeken</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mundlos</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dobyns</surname>
                    <given-names>WB</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Cobblestone-like brain dysgenesis and altered glycosylation in congenital cutis laxa, Debr&#x000e9;-type.</article-title>
                <source>Neurology</source>
                <volume>71</volume>
                <fpage>1602</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">18716235</pub-id>
              </element-citation>
            </ref>
            <ref id="fbln5-cutis-laxa.REF.zhang.1999.981">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>He</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giro</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yong</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tiller</surname>
                    <given-names>GE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davidson</surname>
                    <given-names>JM</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Cutis laxa arising from frameshift mutations in exon 30 of the elastin gene (ELN).</article-title>
                <source>J Biol Chem</source>
                <volume>274</volume>
                <fpage>981</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">9873040</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="fbln5-cutis-laxa.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="fbln5-cutis-laxa.Acknowledgments">
          <title>Acknowledgments</title>
          <p>We thank the families for their participation.</p>
        </sec>
        <sec id="fbln5-cutis-laxa.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>13 March 2014 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>13 October 2011 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>19 March 2009 (et) Review posted live</p>
            </list-item>
            <list-item>
              <p>10 September 2008 (lvm) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
